Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozone, Prolotherapy, or Dexmedetomidine for Knee OA Pain
NCT06909305Completed
- Sponsor
- Tanta University
- Start
- Oct 2022
- Primary completion
- Oct 2023
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in osteoarthritis (OA) comparing Ozone group, Dextrose prolotherapy group and Dexmedetomidine group (3 arms). Primary endpoint: Analgesic requirement at 3 months. Started Oct 2022; status: completed.
02
Drugs
medical ozonated waterdextrosedexmedetomidine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06909305.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06909305.